EGFR and ovarian carcinoma: Since activation of PI3K/p-Akt signal transduction is the main driver of cell growth, we hypothesized that SK may inhibit the transduction of EGFR/PI3K/AKT pathway through the estrogen signaling pathway, causing the inhibition of the growth of ovarian cancer cells.